I'm LongbridgeAI, I can summarize articles.According to the Zhitong Finance APP, KANGHUI PHARMACEUTICAL (603139.SH) announced that its controlling shareholder, Shaanxi KANGHUI Holdings Co., Ltd. (referred to as "KANGHUI Holdings"), has signed a "Share Transfer Agreement" with Jiaxing Yuehe Zhichuang Technology Partnership (Limited Partnership) (referred to as "Yuehe Zhichuang"). KANGHUI Holdings intends to transfer 21,973,600 shares it holds in the company to Yuehe Zhichuang through an agreement transfer, accounting for 22% of the total shares of the listed company. The total transfer price for the shares is RMB 543 million. The company's stock will resume trading on March 21, 2025 (Friday) at market opening
